Skip to main content

Table 1 Patient/client specific clinical and virological characteristics of anti-HDV antibody positives (n = 26) and those with HDV full genome sequenced (n = 6)

From: Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia

Study groups

Lab. Code

Age/sex

Virological characteristics

Clinical characteristics

Anti-HCV

HIV status

HBV viral load

HBeAg

HBV genotype

HDV viral load

HDV genotype

HIV co-infected

ETH3790

34/M

Neg

Pos

3.62

Neg a

A1

9.67 × 10 6

I

WHO stage I

ETH2170

36/F

Pos

Pos

Un

Pos

–

2.27 × 10 5

I

WHO stage IV

ETH2280

33/M

Neg

Pos

Un

Neg

–

7.08 × 10 7

I

WHO stage I

ETH1480

37/F

Neg

Pos

2.72

Neg

D2

–

–

WHO stage II

ETH1570

57/F

Neg

Pos

8.93

Neg

A1

–

–

WHO stage I

ETH4500

30/F

Pos

Pos

3.08

Neg

D4

–

–

WHO stage II

ETH1470

31/M

Pos

Pos

0.48

Neg

–

–

–

WHO stage I

ETH2590

38/F

Neg

Pos

Un

Neg

–

–

–

WHO stage I

ETH2570

46/M

Neg

Pos

Un

Neg

–

–

–

WHO stage I

ETH2150

49/F

Neg

Pos

Un

Neg

–

–

–

WHO stage I

CLD patients

ETH4060

60/M

Neg

Neg

6.34

Neg

A1

3.01 × 10 5

I

Liver cirrhosis

ETH4100

33/M

Neg

Neg

3.15

Neg

A1

2.28 × 10 5

I

HCC

ETH3020

21/F

Neg

Pos

6.90

Pos

A1

–

–

 

ETH3700

25/M

Neg

Neg

7.60

Pos

A1

–

–

Liver ascites + cirrhosisa

ETH4070

23/M

Neg

Neg

4.04

Neg

D3

–

–

 

ETH5730

45/M

Neg

Neg

4.47

Neg

D2

–

–

Chronic hepatitisb

ETH3080

38/F

Neg

Neg

0.60

Nd

–

–

–

Chronic hepatitisc

ETH3120

64/M

Neg

Neg

6.81

Pos

A1

–

–

 

ETH3190

45/M

Neg

Neg

1.56

Neg

–

–

–

Chronic hepatitisd

ETH3320

52/M

Neg

Neg

1.00

Nd

–

–

–

Liver cirrhosisa

ETH3360

22/M

Neg

Neg

0.78

Neg

–

–

–

 

ETH4390

27/M

Pos

Neg

2.01

Neg

–

–

–

 

ETH4380

28/M

Pos

Neg

Un

Neg

–

2.41 × 102

–

Chronic hepatitise

Blood donors

ETH2056

47/M

Neg

Neg

8.39

Neg

D2

6.55 × 10 5

I

–

ETH5660

55/M

Neg

Neg

0.78

Nega

–

–

–

–

ETH5650

38/M

Pos

Neg

Un

Nd

–

–

–

–

  1. Highlighted in bold rows indicate study subjects of their HDV isolate was sequenced. WHO World Health Organization HIV infection disease staging, aBoth HBeAg and HBeAb tests showed non-reactive, bComplicated with schistosomiasis and Hookworm infections, cComplicated with H.pylori infections, dDiagnosed for hepatosplenic and hepatosplenomegaly associated schistosomiasis, e Complicated with Ascaris, Hookworm and P.falciparum infections. Note: Chronic liver disease (CLD) patients with no specified clinical characteristics were classified as ‘undefined’ liver sign and symptoms. Un-undetected. Nd-not done (insufficient sample). HCC-Hepatocellular carcinoma
Back to article page

Virology Journal

ISSN: 1743-422X